pergolide


Also found in: Wikipedia.

pergolide

 [per´go-līd]
a long-acting ergot derivative with dopaminergic properties; used as the mesylate salt in treatment of parkinsonism, administered orally.

pergolide

/per·go·lide/ (per´go-līd) a long-acting ergot derivative with dopaminergic properties; used as the mesylate salt in the treatment of parkinsonism.

pergolide

[per′golīd]
a long-acting ergot derivative with dopaminergic properties, used as the mesylate salt in treatment of parkinsonism. It is administered orally.

pergolide

A drug that simulates the action of dopamine and is used to treat PARKINSON'S DISEASE. A brand name is Celance.
References in periodicals archive ?
Various researches suggested encouraging results of dopamine agonists bromocriptine and pergolide combined with an antidepressant in treatment resistant depression (15,16).
While Pergolide is the drug of choice for most veterinarians, there are several medications that will reduce the production of excessive hormones.
14) Bromocriptine and similar drugs, especially pergolide, also carry a risk of pulmonary, cardiac and retroperitoneal fibrosis, so patients on these drugs must be monitored.
Waters also referred to the Pergolide versus L-Dopa Monotherapy and Positron Emission Tomography (PELMOPET) trial, in which 148 early Parkinson's disease patients were randomized to pergolide and another 146 to levodopa in this 3-year, multicenter, double-blind study (Mov.
Waters also referred to the Pergolide Versus L-dopa Monotherapy and Positron Emission Tomography (PELMOPET) trial in which 148 early Parkinson's disease patients were randomized to pergolide (Permax) and another 146 to levodopa in this 3-year, multicenter, double-blind study (Mov.
1,8,11) In March 2007, the dopamine agonist, pergolide (Permax) was removed from the market by the FDA given concerns related to heart valve damage.
reported in the journal Sleep that "Levodopa with decarboxylase inhibitors, and the dopaminergic agonists pergolide, pramipexole, and ropinirole are effective in the treatment of RLS and PLMD.
The US Food and Drug Administration said today that pergolide, sold under the name Permax and also in generic versions, is being withdrawn at the agency's request.
Medications to treat prolactin-secreting adenomas include bromocriptine, pergolide, and cabergoline.
Patients who take the drugs, pergolide or cabergoline, are four to seven times as likely to suffer damage to their heart valves as patients who don't take either one, according to two studies published in the New England Journal of Medicine (1/4).